MENU
Posters

FEB 26, 2020

Drug Discovery & Development Virtual Event Series 2020



Labroots and the Drug Discovery planning committee are pleased to announce its 3rd annual event in the Drug Discovery & Development Virtual Event Series. The Drug Discovery planning committee carefully planned and selected speakers that best represent the key challenges, opportunities, and issues in the current landscape. These industry leaders discuss the advancements, challenges and successes of discovery and develop new medications and therapies

The theme for this years event is State of the Art and includes the following tracks and topics:

New Practices in Early Phase Drug Discovery >>

  • Alternative In-Vitro Approaches
  • Novel In-Vivo Techniques
  • CRISPR-Cas9 as a Drug Discovery Tool
  • Organ-on-a-Chip and 3D Cultures in Screening

Advancement of Biomarkers in Drug Development >>

  • Liquid Biopsies
  • Precision Medicine
  • PK/PD Modelling and Simulation
  • Receptor Occupancy

Modern Approaches to Clinical Development >>

  • Case Study Keynote
  • Combination Therapies
  • CAR-T/Immunotherapy
  • Precision Medicine
  • Direct to Patient Clinical Trials

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing. 

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.

Use #LRdrug to follow the conversation!


Speakers
  • Professor Anil Gulati, MD, PhD

    Chairman & Chief Executive Officer of Pharmazz, Inc.; Adjunct Professor, Colleges of Pharmacy and Graduate Studies, Midwestern University; Department of Bioengineering, University of Illinois
    BIOGRAPHY
  • Khyati Shah, PhD

    Post Doctoral Research Scholar at University of California, San Francisco
    BIOGRAPHY
  • Erin Edwards, PhD

    Head of Services, Visikol, Inc.
    BIOGRAPHY
  • Chames Kermi, PhD, PharmD

    Postdoctoral Fellow, Chemical and Systems Biology, Stanford University School of Medicine
    BIOGRAPHY
  • Salman Khetani, PhD

    Associate Professor, Department of Bioengineering, University of Illinois at Chicago
    BIOGRAPHY
  • Tomasz Kostrzewski, PhD

    Director, Biology, CN Bio Innovations Limited
    BIOGRAPHY
  • Josh Mahlios, PhD

    Senior Marketing Product Manager, Miltenyi Biotec
    BIOGRAPHY
  • Astrid Nörenberg, PhD

    Managing Director, upcyte technologies GmbH
    BIOGRAPHY
  • Rekha Pal, PhD

    Director, Scientific Engagement, Crown Bioscience, Inc.
    BIOGRAPHY
  • Andrew Ravanelli, PhD

    Senior R&D Scientist, Genome and Epigenome Editing, MilliporeSigma
    BIOGRAPHY
  • Leif Schauser, PhD

    Director, Global Product Management, QIAGEN
    BIOGRAPHY
  • Marc H. Scheetz, PharmD, MSc, FCCP, FCP

    Associate Dean of Research and Professor, College of Pharmacy, Professor, College of Graduate Studies, Departments of Pharmacology and Biomedical Sciences, Director, Pharmacometrics Center of Excellence, Midwestern University
    BIOGRAPHY
  • Olivia Stricker, PhD

    Commercial Business Development Manager, Diapharma Group, Inc.
    BIOGRAPHY
  • Sebastiaan Trietsch, PhD

    Chief Technology Officer, Mimetas -The Organ on a Chip Company
    BIOGRAPHY
  • Jessica Tuohy, PhD

    Scientific Product Manager, DiaPharma Group, Inc.
    BIOGRAPHY
  • Sarah Warren, PhD

    Senior Director of Advanced Applications, NanoString Technologies
    BIOGRAPHY
  • Armin Wolf, PhD

    Chief Scientific Officer, InSphero AG
    BIOGRAPHY

You May Also Like

Presentations

Starting with our 2020 Drug Discovery & Development virtual event, LabRoots is introducing our new agenda format.  We will be offering a full agenda of scheduled presentations throughout the day of the event; including Keynotes, Panels and Sponsored speakers.  We will also be offering unlimited presentations available for immediate On-Demand viewing when the doors to our virtual event open.  The content of our presentations will be delivered by experts in industry and academia.  We hope you enjoy our new format!

  • FEB 26, 2020 1:30 PM PST

    Automated cell separation for drug discovery assays

    Josh Mahlios, PhD
    Senior Marketing Product Manager, Miltenyi Biotec
    BIOGRAPHY
    Sponsored By: Miltenyi Biotec
  • FEB 26, 2020 12:00 PM PST

    Characterizing the role of B cells in Response to Immunotherapy with the NanoString GeoMx Platform

    Sarah Warren, PhD
    Senior Director of Advanced Applications, NanoString Technologies
    BIOGRAPHY
    Sponsored By: NanoString Technologies
  • FEB 26, 2020 10:30 AM PST

    QIAGEN CLC Genomics Workbench 20 - scalable software for NGS data analysis

    Leif Schauser, PhD
    Director, Global Product Management, QIAGEN
    BIOGRAPHY
    Sponsored By: QIAGEN
  • FEB 26, 2020 9:00 AM PST

    CRISPR Based Screening: Advantages of Transcriptional Activators and Inhibitors

    Andrew Ravanelli, PhD
    Senior R&D Scientist, Genome and Epigenome Editing, MilliporeSigma
    BIOGRAPHY
    Sponsored By: MilliporeSigma
  • FEB 26, 2020 7:30 AM PST

    Keynote Presentation: Emerging Drug Combinations: Evolution From Pre-Clinical Discovery to Clinical Development

    Khyati Shah, PhD
    Post Doctoral Research Scholar at University of California, San Francisco
    BIOGRAPHY
  • FEB 26, 2020 6:00 AM PST

    Keynote Presentation: Discovery and Development of a Novel First-in-Class Resuscitative Agent

    Professor Anil Gulati, MD, PhD
    Chairman & Chief Executive Officer of Pharmazz, Inc.; Adjunct Professor, Colleges of Pharmacy and Graduate Studies, Midwestern University; Department of Bioengineering, University of Illinois
    BIOGRAPHY
  • 3D-Micro Tissues in Translational Toxicology and Disease Modelling

    Armin Wolf, PhD
    Chief Scientific Officer, InSphero AG
    BIOGRAPHY
  • CK18 as a Biomarker in NASH Clinical Trials

    Jessica Tuohy, PhD
    Scientific Product Manager, DiaPharma Group, Inc.
    BIOGRAPHY
  • Generation of expanded primary liver cells

    Astrid Nörenberg, PhD
    Managing Director, upcyte technologies GmbH
    BIOGRAPHY
  • Human Tissue models for better therapies

    Sebastiaan Trietsch, PhD
    Chief Technology Officer, Mimetas -The Organ on a Chip Company
    BIOGRAPHY
  • Measuring What Matters: Proliferation and Cell Death Biomarkers for Oncology Research

    Olivia Stricker, PhD
    Commercial Business Development Manager, Diapharma Group, Inc.
    BIOGRAPHY
  • Microfabricated Human Liver Tissues for Drug Development

    Salman Khetani, PhD
    Associate Professor, Department of Bioengineering, University of Illinois at Chicago
    BIOGRAPHY
  • Microphysiological Systems for Human Focused Drug Discovery

    Tomasz Kostrzewski, PhD
    Director, Biology, CN Bio Innovations Limited
    BIOGRAPHY
  • Organoids: A Revolutionary New Tool for Drug Screening

    Rekha Pal, PhD
    Director, Scientific Engagement, Crown Bioscience, Inc.
    BIOGRAPHY
  • Uncovering the mechanism of stress-resistant DNA replication in cancer cells using a modern single-molecule technique

    Uncovering the mechanism of stress-resistant DNA replication in cancer cells using a modern single-molecule technique

    Chames Kermi, PhD, PharmD
    Postdoctoral Fellow, Chemical and Systems Biology, Stanford University School of Medicine
    BIOGRAPHY
  • Using 3D cell culture models and high content confocal imaging to evaluate efficacy and expose toxic liabilities in the drug development pipeline

    Erin Edwards, PhD
    Head of Services, Visikol, Inc.
    BIOGRAPHY
  • Vancomycin: How might Urinary Biomarkers and Precision Dosing create Precision Medicine for the most frequently utilized antibiotic in the hospital?

    Marc H. Scheetz, PharmD, MSc, FCCP, FCP
    Associate Dean of Research and Professor, College of Pharmacy, Professor, College of Graduate Studies, Departments of Pharmacology and Biomedical Sciences, Director, Pharmacometrics Center of Excellence, Midwestern University
    BIOGRAPHY
  • New Practices in Early Phase Drug Discovery
  • Using 3D cell culture models and high content confocal imaging to evaluate efficacy and expose toxic liabilities in the drug development pipeline

    Erin Edwards, PhD
    Head of Services, Visikol, Inc.
    BIOGRAPHY
  • Microfabricated Human Liver Tissues for Drug Development

    Salman Khetani, PhD
    Associate Professor, Department of Bioengineering, University of Illinois at Chicago
    BIOGRAPHY
  • Organoids: A Revolutionary New Tool for Drug Screening

    Rekha Pal, PhD
    Director, Scientific Engagement, Crown Bioscience, Inc.
    BIOGRAPHY
  • Generation of expanded primary liver cells

    Astrid Nörenberg, PhD
    Managing Director, upcyte technologies GmbH
    BIOGRAPHY
  • Human Tissue models for better therapies

    Sebastiaan Trietsch, PhD
    Chief Technology Officer, Mimetas -The Organ on a Chip Company
    BIOGRAPHY
  • 3D-Micro Tissues in Translational Toxicology and Disease Modelling

    Armin Wolf, PhD
    Chief Scientific Officer, InSphero AG
    BIOGRAPHY
  • Microphysiological Systems for Human Focused Drug Discovery

    Tomasz Kostrzewski, PhD
    Director, Biology, CN Bio Innovations Limited
    BIOGRAPHY
  • FEB 26, 2020 12:00 PM PST

    Characterizing the role of B cells in Response to Immunotherapy with the NanoString GeoMx Platform

    Sarah Warren, PhD
    Senior Director of Advanced Applications, NanoString Technologies
    BIOGRAPHY
    Sponsored By: NanoString Technologies
  • FEB 26, 2020 1:30 PM PST

    Automated cell separation for drug discovery assays

    Josh Mahlios, PhD
    Senior Marketing Product Manager, Miltenyi Biotec
    BIOGRAPHY
    Sponsored By: Miltenyi Biotec
  • Advancement of Biomarkers in Drug Development
  • Measuring What Matters: Proliferation and Cell Death Biomarkers for Oncology Research

    Olivia Stricker, PhD
    Commercial Business Development Manager, Diapharma Group, Inc.
    BIOGRAPHY
  • CK18 as a Biomarker in NASH Clinical Trials

    Jessica Tuohy, PhD
    Scientific Product Manager, DiaPharma Group, Inc.
    BIOGRAPHY
  • Vancomycin: How might Urinary Biomarkers and Precision Dosing create Precision Medicine for the most frequently utilized antibiotic in the hospital?

    Marc H. Scheetz, PharmD, MSc, FCCP, FCP
    Associate Dean of Research and Professor, College of Pharmacy, Professor, College of Graduate Studies, Departments of Pharmacology and Biomedical Sciences, Director, Pharmacometrics Center of Excellence, Midwestern University
    BIOGRAPHY
  • Modern Approaches to Clinical Development
  • Uncovering the mechanism of stress-resistant DNA replication in cancer cells using a modern single-molecule technique

    Uncovering the mechanism of stress-resistant DNA replication in cancer cells using a modern single-molecule technique

    Chames Kermi, PhD, PharmD
    Postdoctoral Fellow, Chemical and Systems Biology, Stanford University School of Medicine
    BIOGRAPHY
  • FEB 26, 2020 6:00 AM PST

    Keynote Presentation: Discovery and Development of a Novel First-in-Class Resuscitative Agent

    Professor Anil Gulati, MD, PhD
    Chairman & Chief Executive Officer of Pharmazz, Inc.; Adjunct Professor, Colleges of Pharmacy and Graduate Studies, Midwestern University; Department of Bioengineering, University of Illinois
    BIOGRAPHY
  • FEB 26, 2020 7:30 AM PST

    Keynote Presentation: Emerging Drug Combinations: Evolution From Pre-Clinical Discovery to Clinical Development

    Khyati Shah, PhD
    Post Doctoral Research Scholar at University of California, San Francisco
    BIOGRAPHY
  • FEB 26, 2020 9:00 AM PST

    CRISPR Based Screening: Advantages of Transcriptional Activators and Inhibitors

    Andrew Ravanelli, PhD
    Senior R&D Scientist, Genome and Epigenome Editing, MilliporeSigma
    BIOGRAPHY
    Sponsored By: MilliporeSigma
  • FEB 26, 2020 10:30 AM PST

    QIAGEN CLC Genomics Workbench 20 - scalable software for NGS data analysis

    Leif Schauser, PhD
    Director, Global Product Management, QIAGEN
    BIOGRAPHY
    Sponsored By: QIAGEN

Speakers


  • Professor Anil Gulati, MD, PhD

    Professor Anil Gulati, MD, PhD

    Chairman & Chief Executive Officer of Pharmazz, Inc.; Adjunct Professor, Colleges of Pharmacy and Graduate Studies, Midwestern University; Department of Bioengineering, University of Illinois

    BIOGRAPHY
  • Khyati Shah, PhD

    Khyati Shah, PhD

    Post Doctoral Research Scholar at University of California, San Francisco

    BIOGRAPHY
  • Erin Edwards, PhD

    Erin Edwards, PhD

    Head of Services, Visikol, Inc.

    BIOGRAPHY
  • Chames Kermi, PhD, PharmD

    Chames Kermi, PhD, PharmD

    Postdoctoral Fellow, Chemical and Systems Biology, Stanford University School of Medicine

    BIOGRAPHY
  • Salman Khetani, PhD

    Salman Khetani, PhD

    Associate Professor, Department of Bioengineering, University of Illinois at Chicago

    BIOGRAPHY
  • Tomasz Kostrzewski, PhD

    Tomasz Kostrzewski, PhD

    Director, Biology, CN Bio Innovations Limited

    BIOGRAPHY
  • Josh Mahlios, PhD

    Josh Mahlios, PhD

    Senior Marketing Product Manager, Miltenyi Biotec

    BIOGRAPHY
  • Astrid Nörenberg, PhD

    Astrid Nörenberg, PhD

    Managing Director, upcyte technologies GmbH

    BIOGRAPHY
  • Rekha Pal, PhD

    Rekha Pal, PhD

    Director, Scientific Engagement, Crown Bioscience, Inc.

    BIOGRAPHY
  • Andrew Ravanelli, PhD

    Andrew Ravanelli, PhD

    Senior R&D Scientist, Genome and Epigenome Editing, MilliporeSigma

    BIOGRAPHY
  • Leif Schauser, PhD

    Leif Schauser, PhD

    Director, Global Product Management, QIAGEN

    BIOGRAPHY
  • Marc H. Scheetz, PharmD, MSc, FCCP, FCP

    Marc H. Scheetz, PharmD, MSc, FCCP, FCP

    Associate Dean of Research and Professor, College of Pharmacy, Professor, College of Graduate Studies, Departments of Pharmacology and Biomedical Sciences, Director, Pharmacometrics Center of Excellence, Midwestern University

    BIOGRAPHY
  • Olivia Stricker, PhD

    Olivia Stricker, PhD

    Commercial Business Development Manager, Diapharma Group, Inc.

    BIOGRAPHY
  • Sebastiaan Trietsch, PhD

    Sebastiaan Trietsch, PhD

    Chief Technology Officer, Mimetas -The Organ on a Chip Company

    BIOGRAPHY
  • Jessica Tuohy, PhD

    Jessica Tuohy, PhD

    Scientific Product Manager, DiaPharma Group, Inc.

    BIOGRAPHY
  • Sarah Warren, PhD

    Sarah Warren, PhD

    Senior Director of Advanced Applications, NanoString Technologies

    BIOGRAPHY
  • Armin Wolf, PhD

    Armin Wolf, PhD

    Chief Scientific Officer, InSphero AG

    BIOGRAPHY

Sponsors & Partners

For information on becoming a sponsor or exhibitor, please click here.


Program Committee

To download the Program Committee brochure here.


  • Annette Gilchrist

    An Associate Professor with Midwestern University, Dr. Annette Gilchrist has a PhD in Immunology from the University of Connecticut Health Center and a MS in Biochemistry from the University of Connecticut. Previously, she was with Cue Biotech and Caden Biosciences, companies she ...

    See more See less
  • Matthew Flegal

    Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...

    See more See less
  • Khyati Shah

    Khyati Shah received her Ph.D. in Molecular Pharmacology from the University of the Pacific, Stockton, California. Her graduate research was completed in the lab of Jesika Faridi, Ph.D. Her work focused on the investigation of the mechanism of Akt induced tamoxifen resistance in ...

    See more See less
  • Martin Shaw

    Between 1994-2015 he worked at EKF Diagnostics in Wales (formerly Argutus Medical) where he introduced and promoted a wide range of novel kidney and liver tests, including important biomarkers that are now being evaluated by the IMI (Innovative Medicines Initiative) and FDA as ...

    See more See less
  • Matthew Shipton

    Over the past 16 years, Mr. Shipton has amassed deep domain expertise in cell-based products and services. Currently serving as President of Novabiosis, Inc. Mr. Shipton brings a skill for implementing sales-driven business strategies, an extensive track record of meeting and ...

    See more See less

Event Series


Drug Discovery & Development Virtual Event Series 2025
February 19, 2025 6:00 am Pacific Time

Drug Discovery & Development Virtual Event Series 2025

Drug Discovery & Development Virtual Event Series 2024
February 21, 2024 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2024

Drug Discovery & Development Virtual Event Series 2023
February 22, 2023 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2023

Drug Discovery & Development Virtual Event Series 2022
February 23, 2022 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2022

Drug Discovery & Development Virtual Event Series 2021
February 24, 2021 5:30 am Pacific Time

Drug Discovery & Development Virtual Event Series 2021

Drug Discovery Virtual Event Series 2019
February 27, 2019 6:00 am Pacific Time

Drug Discovery Virtual Event Series 2019

Drug Discovery Virtual Event Series 2018
February 21, 2018 6:00 am Pacific Time

Drug Discovery Virtual Event Series 2018

Help

Demographics

Loading Comments...